Almirall SA Stock Price, News & Analysis
Company Description
Almirall SA (OTC Link: ALMRY) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $2.8B.
ALMRY stock has gained 35.3% over the past year. Shares last traded at $14.29.
This page provides a comprehensive overview of ALMRY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Almirall SA (ALMRY) stock last traded at $14.29. Over the past 12 months, the stock has gained 35.3%. At a market capitalization of $2.8B, ALMRY is classified as a mid-cap stock with approximately 214.8M shares outstanding.
Latest News
Almirall SA has 7 recent news articles. Key topics include conferences, clinical trial. View all ALMRY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Almirall SA (ALMRY) currently stands at 101 shares, up 100.0% from the previous reporting period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Almirall SA (ALMRY) currently stands at 1.0 days, down 50% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 50% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.0 days.
ALMRY Company Profile & Sector Positioning
Almirall SA (ALMRY) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ALMRY often look at related companies in the same sector, including Procaps Group Sa (PROCF), Almirall (LBTSF), Hypera Sa (HYPMY), Sumitomo Dainippon Pharma (SMDPY), and Hikma Pharmaceuticals Plc (HKMPY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ALMRY's relative position within its industry.